Functional deficits in nNOSmu-deficient skeletal muscle: myopathy in nNOS knockout mice
- PMID: 18852886
- PMCID: PMC2559862
- DOI: 10.1371/journal.pone.0003387
Functional deficits in nNOSmu-deficient skeletal muscle: myopathy in nNOS knockout mice
Abstract
Skeletal muscle nNOSmu (neuronal nitric oxide synthase mu) localizes to the sarcolemma through interaction with the dystrophin-associated glycoprotein (DAG) complex, where it synthesizes nitric oxide (NO). Disruption of the DAG complex occurs in dystrophinopathies and sarcoglycanopathies, two genetically distinct classes of muscular dystrophy characterized by progressive loss of muscle mass, muscle weakness and increased fatigability. DAG complex instability leads to mislocalization and downregulation of nNOSmu; but this is thought to play a minor role in disease pathogenesis. This view persists without knowledge of the role of nNOS in skeletal muscle contractile function in vivo and has influenced gene therapy approaches to dystrophinopathy, the majority of which do not restore sarcolemmal nNOSmu. We address this knowledge gap by evaluating skeletal muscle function in nNOS knockout (KN1) mice using an in situ approach, in which the muscle is maintained in its normal physiological environment. nNOS-deficiency caused reductions in skeletal muscle bulk and maximum tetanic force production in male mice only. Furthermore, nNOS-deficient muscles from both male and female mice exhibited increased susceptibility to contraction-induced fatigue. These data suggest that aberrant nNOSmu signaling can negatively impact three important clinical features of dystrophinopathies and sarcoglycanopathies: maintenance of muscle bulk, force generation and fatigability. Our study suggests that restoration of sarcolemmal nNOSmu expression in dystrophic muscles may be more important than previously appreciated and that it should be a feature of any fully effective gene therapy-based intervention.
Conflict of interest statement
Figures




Similar articles
-
Sarcolemmal targeting of nNOSμ improves contractile function of mdx muscle.Hum Mol Genet. 2016 Jan 1;25(1):158-66. doi: 10.1093/hmg/ddv466. Epub 2015 Nov 24. Hum Mol Genet. 2016. PMID: 26604149 Free PMC article.
-
Golgi and sarcolemmal neuronal NOS differentially regulate contraction-induced fatigue and vasoconstriction in exercising mouse skeletal muscle.J Clin Invest. 2010 Mar;120(3):816-26. doi: 10.1172/JCI40736. J Clin Invest. 2010. PMID: 20124730 Free PMC article.
-
Dystrophin R16/17-syntrophin PDZ fusion protein restores sarcolemmal nNOSμ.Skelet Muscle. 2018 Nov 22;8(1):36. doi: 10.1186/s13395-018-0182-x. Skelet Muscle. 2018. PMID: 30466494 Free PMC article.
-
Neuronal nitric oxide synthase (nNOS) splice variant function: Insights into nitric oxide signaling from skeletal muscle.Nitric Oxide. 2019 Jan 1;82:35-47. doi: 10.1016/j.niox.2018.11.004. Epub 2018 Nov 29. Nitric Oxide. 2019. PMID: 30503614 Review.
-
nNOS regulation of skeletal muscle fatigue and exercise performance.Biophys Rev. 2011 Dec;3(4):209-217. doi: 10.1007/s12551-011-0060-9. Epub 2011 Nov 8. Biophys Rev. 2011. PMID: 28510048 Free PMC article. Review.
Cited by
-
Neuronal nitric oxide synthase and affective disorders.IBRO Rep. 2018 Nov 17;5:116-132. doi: 10.1016/j.ibror.2018.11.004. eCollection 2018 Dec. IBRO Rep. 2018. PMID: 30591953 Free PMC article. Review.
-
Co-administration of ibuprofen and nitric oxide is an effective experimental therapy for muscular dystrophy, with immediate applicability to humans.Br J Pharmacol. 2010 Jul;160(6):1550-60. doi: 10.1111/j.1476-5381.2010.00809.x. Br J Pharmacol. 2010. PMID: 20590643 Free PMC article.
-
Episodic Binge-like Ethanol Reduces Skeletal Muscle Strength Associated with Atrophy, Fibrosis, and Inflammation in Young Rats.Int J Mol Sci. 2023 Jan 14;24(2):1655. doi: 10.3390/ijms24021655. Int J Mol Sci. 2023. PMID: 36675170 Free PMC article.
-
Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophin.J Cell Sci. 2010 Jun 15;123(Pt 12):2008-13. doi: 10.1242/jcs.064808. Epub 2010 May 18. J Cell Sci. 2010. PMID: 20483958 Free PMC article.
-
Fatigue and muscle atrophy in a mouse model of myasthenia gravis is paralleled by loss of sarcolemmal nNOS.PLoS One. 2012;7(8):e44148. doi: 10.1371/journal.pone.0044148. Epub 2012 Aug 28. PLoS One. 2012. PMID: 22952904 Free PMC article.
References
-
- Stamler JS, Meissner G. Physiology of nitric oxide in skeletal muscle. Physiol Rev. 2001;81:209–237. - PubMed
-
- Silvagno F, Xia H, Bredt DS. Neuronal nitric-oxide synthase-mu, an alternatively spliced isoform expressed in differentiated skeletal muscle. J Biol Chem. 1996;271:11204–11208. - PubMed
-
- Kobzik L, Reid MB, Bredt DS, Stamler JS. Nitric oxide in skeletal muscle. Nature. 1994;372:546–548. - PubMed
-
- Reid MB, Kobzik L, Bredt DS, Stamler JS. Nitric oxide modulates excitation-contraction coupling in the diaphragm. Comp Biochem Physiol A Mol Integr Physiol. 1998;19:211–218. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous